BIOHK2020Biotech Kaleidoscope - Infinite Possibilities

1

Foreword

BIOHK will bring together the world’s leading, established

and most innovative stakeholders in biotech, pharma and

finance as they collaborate in exploring the future of Hong

Kong’s role as a Biotech hub for the advancement of

Biotech benefits worldwide. BIOHK is expected to

become a signature event in Hong Kong.

2

Why Biotech in Hong Kong ?

Historically, the cyclical nature of biotech revolutions brought

a fresh surge of innovation every two decades.

Hong Kong is at the nexus of converging goals and visions

between key regional and global industry, finance, academic,

research and innovation sectors.

This is the right moment to capitalize on the Hong Kong

Special Administrative Region’s unique position as a strategic

global hub for biotech.

◆ Year 1980 in USA ◆ Year 2000 in Europe◆ Year 2020 in Hong Kong

▪ President Xi Jinping directed state agencies to help

Hong Kong become an international innovation hub

▪ Hong Kong possesses extensive experience in

commercializing innovative technology for industrial

application and branding & marketing

▪ See more details in Appendix V

3

Hong Kong Being the Key Strategic Role

▪ World-class R&D capability

▪ World’s top three Financial Centers for Venture Capital

▪ Gateway to vast China market

▪ Strong International Investor Base

▪ See more in Appendix VI

4

Hong Kong Offers

5

Exhibition Conference & Pitch Session

One2One Partnering Welcome Reception

Public Lectures Biotech Night in Lan Kwai Fong

Greater Bay Area Tour Gala Dinner & Awards Ceremony

Dates: 19-22/08/2020 (Wednesday – Saturday)

Venue: AsiaWorld-Expo (tentative)

Exhibition: Around 300 exhibition booths (could be more)

Speakers: Over 150

Expected visitors: Over 7,000

Highlights:

BIOHK2020 – Event Details

Exhibition> Showcase and Connect

Showcase and Connect your company to the international

biotech scene and vast China market for trading and

collaboration opportunities.

Conference> Share and Inspire

Share and Inspire through invaluable discussions about the

latest regional and international research findings and

industry trends.

One2One Partnering> Promote and Establish

Promote and Establish your company as ‘one to watch’ in

the biotech marketplace by identifying and meeting

prospective partners.

6

BIOHK2020 - Event Highlights

Reach the leading, established, most innovative and freshest voices in Big

Health Industry, Biotech, Drug Development and Pharma. Pitch and Connect

your company to the international biotech scene and vast China market for

trading and collaboration opportunities.

▪ Present your Brand and Innovations

▪ Reinforce Positioning

▪ Build Brand Awareness

▪ Extend Brand Reach

▪ Advertise to Target Market(s)

▪ Valuable Face-Time

▪ Connections with Related Parties

▪ Extend Visibility

▪ Expand Customer Base

▪ Business to Business Trading

7

Exhibition - Showcase and Connect

Enhance Your Awareness

A platform for in-depth discussions and mapping of the latest regional

and international industry and research findings and trends.

8

Gain Unique Insights

Attain the Latest Know-how

Biotech seminars

Conference - Share and Inspire

Sessions will showcase leading thinkers, international scientists, entrepreneurs and

investors from diverse disciplines coming together to exchange research findings, ideas

and professional development experiences across a wide range of topics in interactive

sessions, panel discussions and podium talks.

We are expecting more than 7,000 participants, including over 150 speakers across

multiple panel sessions

*Conference Topics see appendix IV

9

Keynote Speakers

HAN Ji ShengDirector, Institute of Neuroscience, Peking University

LEUNG Chun YingVice Chairman, National Committee of the CPPCC

SONG RuilinChairman, China Pharmaceutical Innovation and Research Development Association

WANG YuFormer Director General, Chinese Center for Disease Control and Prevention (China CDC)

YANG Huan MingCo-founder, Director and Chairman of BGI Group

ZHAN Qi MinExecutive Vice President, Peking University

BIRUKOV G. KonstantinAnesthesiology Endowed Professor, Entrepreneurial Research and Professor of Physiology

GLASS David, JonathanVice President, Research, Regeneron Pharmaceuticals, Inc.

GRAY NancyPresident & CEO, The Gordon Research Conferences

JOHNSON E. BruceChief Clinical Research Officer, Dana-Farber Cancer Institute

YUNG Wai-Kwan, AlfredProfessor, Department of Neuro-Oncology, University of Texas, MD Anderson Cancer Center

ZHAO Guo PingProfessor, Shanghai Institute for Biological Sciences, CAS

ZHOU Guo Ying, GracePresident, Shenzhen International Institute for Biomedical Research

Speakers

**Further Speakers to be Announced

Explore and secure collaborative partnerships and cross-border possibilities.

Promote and establish your company as “one to watch” in the biotech marketplace

by identifying and meeting prospective partners.

Network with industry practitioners,academicians, reputable biopharma firmsand educational institutions

Spot your prospective partners – investors,analysts and partnering companies

Form valuable partnerships with leadingbiotech firms

Meet and greet with high-level executives

Build promising partnerships in a broad-spectrum marketplace

Investors have opportunities to extend business propositions to inventors

Explore Hong Kong as the home for your next business or start-up

10

One2One Partnering - Promote and Establish

Biotech Night in

Lan Kwai Fong > Social Networking

One of Hong Kong’s most popular nightlife hot spots and home to

over 90 restaurants and bars. Join us on Friday night before the

final day of the convention to unwind, celebrate new partnerships

or make new friends.

Greater Bay Area Tour> More Opportunities in GBA

Out of China’s 199 science parks, 111 are biotechnology-related,

with 93 concentrated in the Guangzhou area. Get an in depth look

into this high-tech research and manufacturing epicentre by joining

our Greater Bay Area tour.

Gala Dinner> Awards Ceremony

Held in the last day evening, it is expected government head,

executives, professionals and guests from Hong Kong, GBA and

Central Federal Government, together with BIOHK Convention

delegates will participate in this grand event.

11

BIOHK2020 - Side Event Highlights

InvestorsBiological and

StartupsHealth and

medical industry

• Biotech Entrepreneurs

• CRO

• CMO

• Academia

• R&D Organizations

• Government

• Research Labs

• Leading Consultancy Services

• Science / Industrial Parks

• Incubation Centers

• Clinical & Education Trial Centers

• Diagnostics & Medical Devices

• Biopharmaceutical & Drug Developers

• Clinical Research & Lab Services

• Regenerative Medicine

• Agriculture and Fishery Biotechnology

• Bio manufacturing Platform Technologies

• Genomics / Genetics

• Marine Biotechnology

• Generic Drugs, API and Intermediates

• Smart Hospitals

• Investment, Legal and Financial Services

• And more…

12

BIOHK2020 - Target Audience

BIOHK2020 - Organizing Committees (1)

BASujuanPresident and CEO,

National Foundation for Cancer Research

HAO MarthaBusiness Consultant of Wise

Ally Holding Ltd.

CHAN Sabrina

Senior Executive Director, Hong Kong Association of

the Pharmaceuticals Industry

CHAU Chi Wai, WiltonChairman, Pan Asia Venture

Development Platform (PAVD)

CHEN Ping

Founding Partner, AusvicCapital Limited

CHEN Wei Jie, Danny

Investment Director, Affix Capital

CHUNG Pui Sing, JohnFormer superintendent,

Hong Kong Police Force

HAU Desmond

CEO, Pangenia Inc and DiagCor Life Science Ltd.

HSIAO Wen Luan, WendyProfessor, State Key Laboratory of

Quality Research in Chinese Medicine,Macau University of

Science and Technology

HU Charles

Founder, Ryoden Medical Holdings Limited and Co-

founder, Incando Therapeutics

JIANG ClaireCEO, Queens (Shenzhen) Biotechnology Co., Ltd.

JIANG Ru Hong

Founder, CEO, President and Director,

ASC Therapeutics, Inc.

JE Simon

Chairman of the Board, Great Treasure International / Galaxy

Treasure Group

JIN Kewen

Managing Partner & Co-founder, Serica Capital

LAW Philip

Technology, Media and Technology Leader, Hong Kong,

Deloitte

LE DEU Franck

Senior Partner, Head of Greater China, McKinsey & Company

LEE Tin LapAssociate Professor, School of Biomedical Sciences, Faculty of

Medicine, The Chinese Universityof Hong Kong

LEUNG Yun Chung, Thomas

Lo Ka Chung Charitable Foundation Professor in Pharmaceutical

Sciences Professor and DoULS

LI JamesPresident, Li Law Inc.

LI Ronald

Director, Ming-Wai Lau Centre for Reparative Medicine, HK node,

Karolinska Institutet (KI), Sweden.

LEUNG Chuen YanVice President, Portfolio

Management and Research

LI Ying

Chair Professor of Neuroscience,

City University of Hong Kong

LIN MindinCEO & Editor in Chief,

Global Bio & InvestmentMonthly

LI Xiao Yi, Benjamin

CEO, Lee's Pharmaceutical Holdings

Limited

LO KittyChairman and CEO,

Finet Group Ltd.

LO Yuk Lam

Chairman, Food and Environmental Hygiene, Food and Health Bureau,

Government Secretariat HKSAR

LU Ming Hua

Founding Partner, eChinaHealth

LIU Andy

CEO, CW Data Technologies

13

BIOHK2020 - Organizing Committees (2)

14

MOK Kin Lun, JohnChairman of AML Holdings

Limited

NEARING Kimberly

Board of Directors, The BayHelixGroup

NGUYENPHUOC DonnaPartner, SPARQ Capital

MONTELIUS Lars

Director General, International Iberian Nanotechnology Laboratory

PAN Wendy, JD

Board of Directors, The BayHelix Group

PEI Duan QingPrinciple Investigator and AcademicDirector at the Guangzhou Institutesof Biomedicine and Health (GIBH),

Chinese Academy of Sciences

ORR KevinVice President, Winner

Medical Group

SEGERBLOM BjornHonorary Chairman and Hong Kong Representative, International Iberian

Nanotechnology Laboratory

SHANG Hai LongManaging Director,

Sense Time Hong Kong

SHI Victor

CEO, Adicon Clinical Laboratories

SUN NanDeputy Inspector, ShenzhenAssociation for Science and

Technology

QIAN Pei Yuan

Head and Chair Professor, Department of Ocean Science,

Hong Kong University of Science and Technology

SIU Eric

Chairman of the Hong Kong Center, Macau International Healthcare Think

Tank

SUN FeiAssistant Professor, Chemical and Biological Engineering, The Hong Kong University of Science and

Technology

SUN-Hoffman Lin Head of the North California

Division, BayHelix

TANG C. Mark

Managing Director, Good Health Capital (New York)

TIAN Yao LinCEO, Shenzhen Govita

Medical Laboratory

TSUI Victor

Chief Operating Officer, Powder Pharmaceuticals

Incorporated

UHLEN MathiasPresident, European

Federation of Biotechnology

TSIM Wah Keung, KarlDirector, Centre for Chinese

Medicine R & D

WAN Mu MakiImmediate Past President,

Rotary Club Kowloon Golden Miles

WANG Jing

Centre for Advanced Measurement Science, National Institute of Metrology, China

WANG YitaoDirector, Institute of

Chinese Medical Sciences

WONG AnnyCEO, AlphaSmart World Limited

WONG Bing LouAdjunct Professor, Department

of Biochemistry, Chinese University of Hong Kong

WONG Taam Chi Woon, VivianHon Professor, School of

Chinese Medicine, The University of Hong Kong

WAN Mu Maki

Assistant Professor, Division of Life Science, The Hong Kong

University of Science and Technology

XIE Jia Sheng

Director & Executive President, Guangdong Medical Valley

(GDMV)

BIOHK2020 - Organizing Committees (3)

XIE Min, RobertCEO, Asia Investment Fund

Management Limited

YANG HaidingExecutive Director and Medical Team Leader of

Cathy Capital

YANG Meng Su, MichaelHead and Yeung Kin Man Chair

Professor, Department of BiomedicalSciences, City University of Hong Kong

YANG RayPartner, Marathon Venture Partners

YANG SteveChief Business Officer &Executive Vice President,WuXi AppTec Co., Ltd.

YU DuncanPresident, MGI

YUNG Kin Lam, KenProfessor and Associate Head,

Faculty of Science,Hong Kong Baptist University

ZHANG Jimmy

Founding Member and Former Chairman of

BayHelix Group

ZHOU Guo Ying, Grace

President, Shenzhen International Institute for Biomedical Research

15

BIOHK2020 Operation Team

17

Nancy CHUENCHAI

Project OfficerHong Kong BiotechnologyOrganization

BSc (Hons) in Conventionand Event ManagementSchool of Hotel andTourism ManagementThe Hong Kong PolytechnicUniversity

Dior LAI

Project OfficerHong Kong BiotechnologyOrganization

BSc (Hons) in Conventionand Event ManagementSchool of Hotel and TourismManagementThe Hong Kong PolytechnicUniversity

George CHAN

Management InformationSystems EngineerHong Kong BiotechnologyOrganization

BEng in Computer ScienceHong Kong University ofScience and Technology

Lori TSANG

Marketing OfficerHong Kong Biotechnology Organization

BA (Hons) Marketing ManagementLeeds Metropolitan University

Louvinia WONG

Project OfficerHong Kong BiotechnologyOrganization

Biological Sciences BSc (Hons) (Physiology with Pharmacology and Neuroscience)University of Leicester

16

v

Organizers

全面展會管理

Co-organizers

17

Diamond Sponsors

18

Special Supporting Organizations

Supporting Organizations

19

Global Partners

20

Official Carrier

21

Official Hotel Partner

Media Partners

Conclusion

BIOHK2020 will open a new era in biotechnology in

Hong Kong.

Join us at this event to witness the start of a new

wave of innovations that will benefit well-being

worldwide.

22

Thank You!

Contact

Website: bio-hk.com Email: info@bio-hk.com Tel: +852 2799 7688 Fax: +852 2111 9762

Scan and Find us

Please contact us and we will be happy to help you to

plan your BIOHK2020 experience!

hkbiohkbio-orgBIOHK202023

Appendix

24

Hong Kong Biotechnology Organization (HKBIO) established in 2010 by reputable industry

and esteemed academic representatives, is a non-profit organization which continuously

strives to promote Hong Kong as the biotech hub of Asia. HKBIO has organized and

sponsored several successful events in the past that highlighted the substantial potential of

Hong Kong’s Biotechnology sector.

The BayHelix Group is a non-profit professional organization of business leaders with a

mission to shape the growth of the life sciences and healthcare industry. Founded in 2001

in the San Francisco Bay Area, BayHelix has grown to over 800 members globally with a

strong presence in China and the US. BayHelix aspires to foster and create business

opportunities, supply and nurture leaders for the community, and network and share

information and experience among its members.

25

Appendix I:

About the Organizers

HKBIO's Past Events

2018 Hong Kong Biotech Horizons

A mobile conference with the aim of promoting biotech and connecting professionals from a cross section

of industries to create a diverse network that can foster the biotech industry’s development and innovation.

2017 Hong Kong Biotech Horizons

“Global Congress on Biotechnology: Diagnostics and Therapeutics” brought together

communities of scientific researchers, technology developers and entrepreneurs seeking progress in

translational science.

HKBIO Horizon Series

12th International Conference on Brain Energy Metabolism-linked leading experts and young, emerging neuroscientists worldwide, all interested in diverse aspects of brain energy metabolism.

HKBIO Cancer Research FundDedicated to furthering the cause of preventing and curing cancer by promoting clinical cancer research in Hong Kong and China.

26

Appendix II:

About HKBIO

Out of China’s 199 science parks, 111 arebiotechnology parks, with 93 concentrated in theGuangzhou area.

Some USD45 billion was invested in biotech companies inChina between 2014-2017 – more than USD12 billion of itcoming from Chinese venture capital and other private firms.

China’s DNA sequencing market is expected to grow to 18.3billion RMB by 2022 from 7.2 billion RMB last year, greatlysurpassing the overall global market because of the country’srising income and growing investments in health careinfrastructure.

Hong Kong Stock Exchange’s biggest listing reform in 25 years(effective 30 April 2018) saw the establishment of a newBiotech chapter allowing biotech companies that are pre-revenue or insufficiently profitable to be listed — transformingHong Kong into the world’s second largest biotechnology listingplatform.

Out of the top Asia-Pacific IPOs in 2016, four of the top fivewere China based biotech companies.

Guangdong, Hong Kong and Macao – (key regions in theGreater Bay Area (GBA) established in 2017) promoted jointand coordinated regional economic development.

27

Appendix III:

Biotechnology Trends in 2020

• 5G + Data Transmission

• AI + Biotech

• Anti-ageing

• Antibiotics & Antimicrobial Resistance

• Applications of Bioengineering

• Bioethics, Law & Investment

• Biotech in Guangdong-HK-Macau GBA

• Biotech in Society and Culture

• Biotech IPO + HKEX

• Block Chain + Biotech

• Business Development & Emerging

• Opportunities in Biotech

• Cancer Therapies

• Cardiovascular Diseases, Therapies & Diagnostics

28

• Clinical Trials

• Diagnostics & Medical Devices

• Digitization of Healthcare

• Environmental Biotechnology

• Genome Editing and Gene Therapy

• Glioblastoma

• Global Cell & Gene Therapeutics and Regulatory Trends

• Infectious Diseases and Vaccines

• Intellectual Property Rights

• International Strategic Perspectives

• Lab-on-a-chip

• Marine Biotechnology

• Medical Device Market Penetration

• Microbiome & Probiotics

• Modernization of Chinese Medicine

• New Drug Discovery

• New Therapies

• Oncology

• One Belt One Road

• Pharma

• Precision Medicine and Big Data

• Present and Future Bioethics

• Public Health

• Rare Diseases

• Regenerative Medicine & Immunology

• Stem Cell Research

• Translational Medical Genomics

• And More…

Appendix IV: Topics for the Convention

▪ Hong Kong Exchanges and Clearing Limited has enabled pre-revenue biotech companies to be listed on the Main Board – a milestone in stock market history

▪ Innovation and Technology (I&T) fund has financed over 540 biotech projects and aims to attract more world-class scientific research institutions & technology enterprises

▪ About 1,300 I&T companies and “incubates” have established themselves in the Hong Kong Science Park (HKSP) and Cyberport

▪ Currently, the city has approximately 250-300 biotech-related companies

▪ Hong Kong is a preferred destination for multinationals to set up offices and regional headquarters

▪ Hong Kong’s start-up scene has experienced phenomenal growth in recent years

▪ Several incubators and accelerators offer start-ups comprehensive incubation programs to promote the local biotech scene

29

Appendix V:Hong Kong Being the Key Strategic Role

▪ Active entrepreneurial ecosystem

▪ Free & open economy

▪ Gateway to vast China market

▪ Excellent fund-raising platform

▪ Established financial & legal systems

▪ Sound regulatory regime

▪ Transparent vetting process

▪ IP protection

▪ Business friendly taxes

▪ Innovation & Technology (I&T) fund

▪ Reputable quality control & assurance

▪ A supportive government

30

Appendix VI: Hong Kong Offers